Gavi CEO Dr Seth Berkley answers questions about the planned deployment of Merck’s rVSV-ZEBOV vaccine to counter the ongoing Ebola outbreak in the north west of the Democratic Republic of the Congo (DRC).

Guinea is having its first Ebola outbreak since 2016, when West Africa experienced the biggest outbreak ever seen. Could the vaccine that contained previous outbreaks soon be redeployed?

The tracking of antibodies in Ebola survivors suggests they wax and wane, which could make vaccine booster shots necessary.

The virus is always present in nature and when circumstances allow, it may jump from one species to another.

Guinea declares end of Ebola outbreak after 42 days without new cases. Outbreak resulted in 23 likely cases, 12 deaths since February. Success attributed to community buy-in, capacity building and vaccination.

Under the leadership of the Ministry of Health and Public Hygiene, and with the support of Gavi, the Vaccine Alliance, the World Health Organization (WHO), UNICEF and PATH, Guinea today officially introduced the malaria vaccine into its Expanded…